IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma
BACKGROUND: In promoting tumour malignancy IL-6 signalling is considered to have an important role. However, the biological roles of IL-6 on radiosensitivity in oral squamous cell carcinoma (OSCC) remain largely unclear. The objective of this study is to determine the effects and molecular mechanism...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104896/ https://www.ncbi.nlm.nih.gov/pubmed/27736845 http://dx.doi.org/10.1038/bjc.2016.327 |
_version_ | 1782466812022095872 |
---|---|
author | Matsuoka, Yuichiro Nakayama, Hideki Yoshida, Ryoji Hirosue, Akiyuki Nagata, Masashi Tanaka, Takuya Kawahara, Kenta Sakata, Junki Arita, Hidetaka Nakashima, Hikaru Shinriki, Satoru Fukuma, Daiki Ogi, Hidenao Hiraki, Akimitsu Shinohara, Masanori Toya, Ryo Murakami, Ryuji |
author_facet | Matsuoka, Yuichiro Nakayama, Hideki Yoshida, Ryoji Hirosue, Akiyuki Nagata, Masashi Tanaka, Takuya Kawahara, Kenta Sakata, Junki Arita, Hidetaka Nakashima, Hikaru Shinriki, Satoru Fukuma, Daiki Ogi, Hidenao Hiraki, Akimitsu Shinohara, Masanori Toya, Ryo Murakami, Ryuji |
author_sort | Matsuoka, Yuichiro |
collection | PubMed |
description | BACKGROUND: In promoting tumour malignancy IL-6 signalling is considered to have an important role. However, the biological roles of IL-6 on radiosensitivity in oral squamous cell carcinoma (OSCC) remain largely unclear. The objective of this study is to determine the effects and molecular mechanisms of IL-6 on radiosensitivity in OSCC. METHODS: Two OSCC cell lines, and OSCC tissue samples with radioresistant cells were used. We examined the effects of IL-6, or tocilizumab, a humanised anti-human IL-6 receptor antibody, or both on radiosensitivity and DNA damage after X-ray irradiation in vitro. In addition, we investigated the involvement of the Nrf2-antioxidant pathway in IL-6-mediated radioresistant mechanisms using OSCC cell lines and tissues. RESULTS: Increased levels of IL-6 suppressed radiation-induced cell death, and the blockade of IL-6 signalling by tocilizumab sensitised tumour cells to radiation. The radioresistant effect of IL-6 was associated with decreased DNA damage after radiation. We also found that IL-6 promotes the activation of not only the downstream molecule STAT3 but also the Nrf2-antioxidant pathway, leading to a significant decrease in oxidative stress by upregulating Mn-SOD. CONCLUSIONS: These results indicate that the blockade of IL-6 signalling combined with conventional radiotherapy could augment the treatment response and survival rate in patients with radioresistant OSCC. |
format | Online Article Text |
id | pubmed-5104896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51048962017-11-08 IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma Matsuoka, Yuichiro Nakayama, Hideki Yoshida, Ryoji Hirosue, Akiyuki Nagata, Masashi Tanaka, Takuya Kawahara, Kenta Sakata, Junki Arita, Hidetaka Nakashima, Hikaru Shinriki, Satoru Fukuma, Daiki Ogi, Hidenao Hiraki, Akimitsu Shinohara, Masanori Toya, Ryo Murakami, Ryuji Br J Cancer Translational Therapeutics BACKGROUND: In promoting tumour malignancy IL-6 signalling is considered to have an important role. However, the biological roles of IL-6 on radiosensitivity in oral squamous cell carcinoma (OSCC) remain largely unclear. The objective of this study is to determine the effects and molecular mechanisms of IL-6 on radiosensitivity in OSCC. METHODS: Two OSCC cell lines, and OSCC tissue samples with radioresistant cells were used. We examined the effects of IL-6, or tocilizumab, a humanised anti-human IL-6 receptor antibody, or both on radiosensitivity and DNA damage after X-ray irradiation in vitro. In addition, we investigated the involvement of the Nrf2-antioxidant pathway in IL-6-mediated radioresistant mechanisms using OSCC cell lines and tissues. RESULTS: Increased levels of IL-6 suppressed radiation-induced cell death, and the blockade of IL-6 signalling by tocilizumab sensitised tumour cells to radiation. The radioresistant effect of IL-6 was associated with decreased DNA damage after radiation. We also found that IL-6 promotes the activation of not only the downstream molecule STAT3 but also the Nrf2-antioxidant pathway, leading to a significant decrease in oxidative stress by upregulating Mn-SOD. CONCLUSIONS: These results indicate that the blockade of IL-6 signalling combined with conventional radiotherapy could augment the treatment response and survival rate in patients with radioresistant OSCC. Nature Publishing Group 2016-11-08 2016-10-13 /pmc/articles/PMC5104896/ /pubmed/27736845 http://dx.doi.org/10.1038/bjc.2016.327 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Translational Therapeutics Matsuoka, Yuichiro Nakayama, Hideki Yoshida, Ryoji Hirosue, Akiyuki Nagata, Masashi Tanaka, Takuya Kawahara, Kenta Sakata, Junki Arita, Hidetaka Nakashima, Hikaru Shinriki, Satoru Fukuma, Daiki Ogi, Hidenao Hiraki, Akimitsu Shinohara, Masanori Toya, Ryo Murakami, Ryuji IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma |
title | IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma |
title_full | IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma |
title_fullStr | IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma |
title_full_unstemmed | IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma |
title_short | IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma |
title_sort | il-6 controls resistance to radiation by suppressing oxidative stress via the nrf2-antioxidant pathway in oral squamous cell carcinoma |
topic | Translational Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104896/ https://www.ncbi.nlm.nih.gov/pubmed/27736845 http://dx.doi.org/10.1038/bjc.2016.327 |
work_keys_str_mv | AT matsuokayuichiro il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT nakayamahideki il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT yoshidaryoji il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT hirosueakiyuki il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT nagatamasashi il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT tanakatakuya il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT kawaharakenta il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT sakatajunki il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT aritahidetaka il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT nakashimahikaru il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT shinrikisatoru il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT fukumadaiki il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT ogihidenao il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT hirakiakimitsu il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT shinoharamasanori il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT toyaryo il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma AT murakamiryuji il6controlsresistancetoradiationbysuppressingoxidativestressviathenrf2antioxidantpathwayinoralsquamouscellcarcinoma |